Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The allergy questionnaire for athletes provides value in ruling‐out exercise‐induced bronchoconstriction
Allergy ( IF 12.6 ) Pub Date : 2019-04-04 , DOI: 10.1111/all.13778 Hayden Allen 1 , James H Hull 2 , Susan H Backhouse 1 , Taidgh De Carné 3 , Lygeri Dimitriou 3 , Oliver J Price 1
Allergy ( IF 12.6 ) Pub Date : 2019-04-04 , DOI: 10.1111/all.13778 Hayden Allen 1 , James H Hull 2 , Susan H Backhouse 1 , Taidgh De Carné 3 , Lygeri Dimitriou 3 , Oliver J Price 1
Affiliation
To the Editor, Exercise‐induced bronchoconstriction (EIB) refers to a condition characterised by expiratory airflow limitation during physical activ‐ ity and is one of the most common causes of exertional breathing difficulty in young athletic individuals.1 Due to the limited value of a symptom‐based approach to diagnosis,2 it is now widely recognised that EIB should be objectively confirmed via indirect bronchoprovo‐ cation testing before initiating treatment, with eucapnic voluntary hyperpnoea (EVH) often endorsed for this purpose.3 Although the feasibility of EVH testing is well established, the practicalities and associated cost of assessment is substantial and therefore not widely available as part of routine diagnostic work‐up across primary and secondary care. The development of simple yet robust clinical tools to aid the assessment of airway health in athletic individuals is therefore required. The Allergy Questionnaire for Athletes (AQUA) was originally de‐ veloped and validated as a reliable means to quantify the severity of allergic disease in athletes (specificity: 97.1% and sensitivity: 58.3%).4 Over the past decade, the relevant respiratory symptom components
中文翻译:
运动员的过敏问卷在排除运动引起的支气管收缩方面提供了价值
因此,需要开发简单而强大的临床工具来帮助评估运动员的气道健康。运动员过敏问卷 (AQUA) 最初是作为量化运动员过敏性疾病严重程度的可靠方法而开发和验证的(特异性:97.1%,敏感性:58.3%)。4 在过去十年中,相关呼吸道症状组件
更新日期:2019-04-04
中文翻译:
运动员的过敏问卷在排除运动引起的支气管收缩方面提供了价值
因此,需要开发简单而强大的临床工具来帮助评估运动员的气道健康。运动员过敏问卷 (AQUA) 最初是作为量化运动员过敏性疾病严重程度的可靠方法而开发和验证的(特异性:97.1%,敏感性:58.3%)。4 在过去十年中,相关呼吸道症状组件